Cost-effective screening for Chlamydia trachomatis: are DNA amplification assays the answer?

Sex Transm Dis. 1998 Sep;25(8):403-7. doi: 10.1097/00007435-199809000-00002.
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • Chlamydia Infections / diagnosis*
  • Chlamydia Infections / economics
  • Chlamydia trachomatis
  • Cost-Benefit Analysis
  • Female
  • Gene Amplification*
  • Humans
  • Immunoassay
  • Sensitivity and Specificity